As we observed that the expression levels of NLRP3/IL-1β were downregulated in the innate immune cells from COVID-19 patients, we wanted to further explore the protein encoded by the SARS-CoV-2 genome involved in the downregulated NLRP3 inflammasome pathway. This evidence concerns the gene IL1B and COVID-19.